HomeMLTX • NASDAQ
Follow
MoonLake Immunotherapeutics
Previous close
$50.21
Day range
$48.70 - $52.92
Year range
$17.82 - $64.98
Market cap
3.21B USD
Avg Volume
589.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
0.11%
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 15.03M | -9.99% |
Net income | -7.44M | 56.53% |
Net profit margin | — | — |
Earnings per share | -0.12 | 72.09% |
EBITDA | -15.03M | 9.99% |
Effective tax rate | -0.56% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 511.01M | 608.60% |
Total assets | 526.54M | 585.21% |
Total liabilities | 13.05M | 61.57% |
Total equity | 513.49M | — |
Shares outstanding | 62.87M | — |
Price to book | 6.12 | — |
Return on assets | -7.32% | — |
Return on capital | -7.46% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -7.44M | 56.53% |
Cash from operations | -12.34M | -6.45% |
Cash from investing | 116.87M | 1,080.30% |
Cash from financing | 28.42M | 749,475.71% |
Net change in cash | 133.00M | 7,928.16% |
Free cash flow | -8.58M | -51.62% |
About
Founded
2020
Headquarters
Website
Employees
50